-
Kenya's economy faces climate change risks: World Bank
-
French culture boss accused of mass drinks spiking to humiliate women
-
US Afghans in limbo after Washington soldier attack
-
Nasdaq rallies again while yen falls despite BOJ rate hike
-
US university killer's mystery motive sought after suicide
-
IMF approves $206 mn aid to Sri Lanka after Cyclone Ditwah
-
Rome to charge visitors for access to Trevi Fountain
-
Stocks advance with focus on central banks, tech
-
Norway crown princess likely to undergo lung transplant
-
France's budget hits snag in setback for embattled PM
-
Volatile Oracle shares a proxy for Wall Street's AI jitters
-
Japan hikes interest rates to 30-year-high
-
Brazil's top court strikes down law blocking Indigenous land claims
-
'We are ghosts': Britain's migrant night workers
-
Asian markets rise as US inflation eases, Micron soothes tech fears
-
Trump signs $900 bn defense policy bill into law
-
EU-Mercosur deal delayed as farmers stage Brussels show of force
-
Harrison Ford to get lifetime acting award
-
Trump health chief seeks to bar trans youth from gender-affirming care
-
Argentine unions in the street over Milei labor reforms
-
Brazil open to EU-Mercosur deal delay as farmers protest in Brussels
-
Brussels farmer protest turns ugly as EU-Mercosur deal teeters
-
US accuses S. Africa of harassing US officials working with Afrikaners
-
ECB holds rates as Lagarde stresses heightened uncertainty
-
Trump Media announces merger with fusion power company
-
Stocks rise as US inflation cools, tech stocks bounce
-
Zelensky presses EU to tap Russian assets at crunch summit
-
Danish 'ghetto' residents upbeat after EU court ruling
-
ECB holds rates but debate swirls over future
-
Bank of England cuts interest rate after UK inflation slides
-
Have Iran's authorities given up on the mandatory hijab?
-
British energy giant BP extends shakeup with new CEO pick
-
EU kicks off crunch summit on Russian asset plan for Ukraine
-
Sri Lanka plans $1.6 bn in cyclone recovery spending in 2026
-
Most Asian markets track Wall St lower as AI fears mount
-
Danish 'ghetto' tenants hope for EU discrimination win
-
What to know about the EU-Mercosur deal
-
Trump vows economic boom, blames Biden in address to nation
-
ECB set to hold rates but debate swirls over future
-
EU holds crunch summit on Russian asset plan for Ukraine
-
Nasdaq tumbles on renewed angst over AI building boom
-
Billionaire Trump nominee confirmed to lead NASA amid Moon race
-
CNN's future unclear as Trump applies pressure
-
German MPs approve 50 bn euros in military purchases
-
EU's Mercosur trade deal hits French, Italian roadblock
-
Warner Bros rejects Paramount bid, sticks with Netflix
-
Crude prices surge after Trump orders Venezuela oil blockade
-
Warner Bros. Discovery rejects Paramount bid
-
Doctors in England go on strike for 14th time
-
Ghana's Highlife finds its rhythm on UNESCO world stage
'Revolutionary': Scientists create mice with two fathers
Scientists have created eggs using the cells of male mice for the first time, leading to the birth of seven mice with two fathers, according to research Wednesday hailed as "revolutionary".
The technique pioneered in the proof-of-concept experiment is a long way from potentially being used in humans, with obstacles including a low success rate, adaptation concerns and wide-ranging ethical considerations.
But the breakthrough raises the prospect of a raft of new reproductive possibilities, including that gay male couples -- or even a single man -- could have a biological child without needing a female egg.
The research, published in the journal Nature, was carried out by a team of scientists in Japan led by developmental biologist Katsuhiko Hayashi of the Osaka and Kyushu universities.
Hayashi and his team previously found a way to take skin cells from a female mouse and transform them into an egg that could be used to give birth to healthy pups.
For their latest research, the team aimed to do the same for male cells.
Just like humans, male mice have both an X and Y chromosome, while females have two X chromosomes.
The scientists took skin cells from the tail of a male mouse and, in a dish, turned them into what are called induced pluripotent stem cells, which can become any type of cell.
During this process around six percent of the cells lost their Y chromosome, leaving only an X chromosome -- meaning they were what is known as XO.
Using a fluorescent protein and a drug called reversine, the researchers managed to duplicate the existing X chromosome in these cells, creating an XX set.
- One percent success rate -
The cells were then used to create eggs, which were fertilised with the sperm of a different male mouse and implanted into the uteruses of surrogate female mice.
Out of 630 attempts, seven pups were born, representing a success rate of just over one percent.
The pups do not show any sign of abnormalities and are fertile themselves, the study said.
Hayashi, who first presented the findings at the Third International Summit on Human Genome Editing in London last week, warned that many obstacles remained before the technology could be used for humans.
"There is a big difference between a mouse and a human," he told the summit.
Nitzan Gonen, the head of the sex determination laboratory at Israel's Bar-Ilan University, told AFP that it was a "revolutionary paper", while cautioning that there was a long way to go.
Theoretically, the technique could allow two same-sex male partners to have a baby, one providing the sperm and the other the egg, said Gonen, who was not involved in the research.
One man could even provide both the sperm and the egg, which Gonen said could be "a bit more like cloning, like what they did with Dolly the sheep".
- 'Milestone' -
Jonathan Bayerl and Diana Laird, stem cell and reproductive experts at the University of California, San Francisco, said it was not yet known if the process would even work with human stem cells.
Nonetheless, the research marks "a milestone in reproductive biology", they commented in Nature.
One potential future application could be to bring an endangered species with only one surviving male back from the brink, provided there was a suitable female surrogate from another species, they said.
But Gonen warned that the process was currently "extremely inefficient", with 99 percent of the embryos not surviving.
And while pregnancy takes only three weeks in mice, it lasts nine months in humans, creating much more time for something to go wrong, she added.
If she had to guess, Gonen estimated that "scientifically speaking" the technique could be ready for humans in around 10 to 15 years.
But that did include the time it could take to wade through the ethical considerations that may arise, she added.
"The fact that we can do something does not necessarily mean we want to do it -- especially when we are talking about a new human being."
P.Gonzales--CPN